Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets


The European Union multi-disciplinary Personalised RNA interference to Enhance the Delivery of Individualised Cytotoxic and Targeted therapeutics (PREDICT) consortium has recently initiated a framework to accelerate the development of predictive biomarkers of individual patient response to anti-cancer agents. The consortium focuses on the identification of… (More)
DOI: 10.1186/gm174


3 Figures and Tables